Abstract:Genome projects[1] are yielding protein sequences for which there is no knowledge about function or conformation. The draft human genome has now been available and the exploitation of this unique source of knowledge is a major challenge for biology. In parallel with these sequencing projects, there are structural genomics initiatives involving the determination of the conformations of uncharacterized proteins in the genomes with the particular aim of determining function. In addition, gene expression arrays are providing a mass of data that require analysis to relate protein sequences to activity under different conditions and in different cellular locations. Knowledge of the structure and function of the relevant proteins, revealed by crystallography and NMR, is central to the interpretation and exploitation of this pool of biological information. Threedimensional structure can guide further experiments to probe activity and direct the systematic design of therapeutic agents for diseases. The experimental determination of protein structure remains difficult. There are large disparities between the numbers of protein sequences. Protein modeling provides a valuable approach to maximize the biological knowledge that can be obtained given these disparities. Accordingly, the task of the Structural Bioinformatics is the development of protein modeling algorithms and the application of the technology to systems of interests. Methodologies based on the known protein structures from experiments have been developed to predict 3D structures from a 1D sequence information, which is known as the homology modeling. It has become a reliable tool as long as the homologue with experimental 3D structure of significant similarity(usually greater than 35%) could be found. Other methods, for example, ab initio molecular dynamics, is still too slow to predict structure of a real protein. Often the structures of many drug targets are not available. The structural bioinformatics tools are needed to generate them readily to initiate drug design processes. We have predicted many protein structures using homology modeling to facilitate the computer aided drug design, which include database screening, pharmacophore search, docking and molecular dynamics conformation search. To join the worldwide efforts[17] against H5N1 viruses which experience rapid mutation and become increasingly drugresistant. A homology model of the H5N1NA[8] from the highly pathogenic chicken H5N1 A viruses isolated during the 2003– 2004 influenza outbreaks in Japan was built based on the crystal structure of N9NA complexed with DANA (PDB code: 1F8B). It was found that the traditional constituent

Structural chemistry and therapeutic intervention of protein-protein interactions in immune response, human immunodeficiency virus entry, and apoptosis.

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Internet Resources Related to Drug Action and Human Response: A Review

Targeting Protein-Protein Interactions: a Promising Avenue of Anti-Hiv Drug Discovery.

Structural Approaches to Probing Metal Interaction with Proteins

Protein crystallography and infectious diseases

Chemical and structural biology of nucleic acids and protein-nucleic acid complexes for novel drug discovery

Progress in Small Molecular Inhibitors of Protein-Protein Interactions

Immunoglobulin superfamily proteins: Targets for medicinal chemistry research

Structure, Function and Modulation of Chemokine Receptors: Members of the G-Protein-coupled Receptor Superfamily.

Structural bioinformatics and computer aided design of novel drugs and functional proteins

Protein Conformational Transitions Coupling with Ligand Interactions: Simulations from Molecules to Medicine

Structure-based Drug Design Strategies in the Development of Small Molecule Inhibitors Targeting Bcl-2 Family Proteins

Structure-based drug design: From nucleic acid to membrane protein targets

Virtual Screening, Biological Evaluation, And 3d-Qsar Studies Of New Hiv-1 Entry Inhibitors That Function Via The Cd4 Primary Receptor

Progress in Studies of Structure, Mechanism and Antagonists Interaction of GPCR Co-Receptors for HIV.

Crystal Structure and Structural Mechanism of a Novel Anti-Human Immunodeficiency Virus Andd-Amino Acid-Containing Chemokine

Specific Noncovalent Interactions at Protein-Ligand Interface: Implications for Rational Drug Design.

Designed Multiple Ligands: an Emerging Anti-HIV Drug Discovery Paradigm

Structural Biology for the Molecular Insight between Aptamers and Target Proteins

Cellular proteins as potential targets for antiretroviral therapy